These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 25746232)

  • 1. Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.
    Lee H; Lei H; Santarsiero BD; Gatuz JL; Cao S; Rice AJ; Patel K; Szypulinski MZ; Ojeda I; Ghosh AK; Johnson ME
    ACS Chem Biol; 2015 Jun; 10(6):1456-65. PubMed ID: 25746232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
    Báez-Santos YM; St John SE; Mesecar AD
    Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.
    Báez-Santos YM; Mielech AM; Deng X; Baker S; Mesecar AD
    J Virol; 2014 Nov; 88(21):12511-27. PubMed ID: 25142582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional characterization of MERS coronavirus papain-like protease.
    Lin MH; Chuang SJ; Chen CC; Cheng SC; Cheng KW; Lin CH; Sun CY; Chou CY
    J Biomed Sci; 2014 Jun; 21(1):54. PubMed ID: 24898546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structurally Guided Removal of DeISGylase Biochemical Activity from Papain-Like Protease Originating from Middle East Respiratory Syndrome Coronavirus.
    Daczkowski CM; Goodwin OY; Dzimianski JV; Farhat JJ; Pegan SD
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication.
    Ratia K; Pegan S; Takayama J; Sleeman K; Coughlin M; Baliji S; Chaudhuri R; Fu W; Prabhakar BS; Johnson ME; Baker SC; Ghosh AK; Mesecar AD
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16119-24. PubMed ID: 18852458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors.
    Kilianski A; Mielech AM; Deng X; Baker SC
    J Virol; 2013 Nov; 87(21):11955-62. PubMed ID: 23986593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.
    Tomar S; Johnston ML; St John SE; Osswald HL; Nyalapatla PR; Paul LN; Ghosh AK; Denison MR; Mesecar AD
    J Biol Chem; 2015 Aug; 290(32):19403-22. PubMed ID: 26055715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
    Yang X; Chen X; Bian G; Tu J; Xing Y; Wang Y; Chen Z
    J Gen Virol; 2014 Mar; 95(Pt 3):614-626. PubMed ID: 24362959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications.
    Lee H; Cao S; Hevener KE; Truong L; Gatuz JL; Patel K; Ghosh AK; Johnson ME
    ChemMedChem; 2013 Aug; 8(8):1361-72. PubMed ID: 23788528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease.
    Chou CY; Lai HY; Chen HY; Cheng SC; Cheng KW; Chou YW
    Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):572-81. PubMed ID: 24531491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Papain-Like Protease Potential Inhibitors-In Silico Quantitative Assessment.
    Stasiulewicz A; Maksymiuk AW; Nguyen ML; Bełza B; Sulkowska JI
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity.
    Barretto N; Jukneliene D; Ratia K; Chen Z; Mesecar AD; Baker SC
    J Virol; 2005 Dec; 79(24):15189-98. PubMed ID: 16306590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.
    Kandeel M; Kitade Y; Fayez M; Venugopala KN; Ibrahim A
    J Med Virol; 2021 Mar; 93(3):1581-1588. PubMed ID: 32902889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme.
    Ratia K; Saikatendu KS; Santarsiero BD; Barretto N; Baker SC; Stevens RC; Mesecar AD
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5717-22. PubMed ID: 16581910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus.
    Chou CY; Chien CH; Han YS; Prebanda MT; Hsieh HP; Turk B; Chang GG; Chen X
    Biochem Pharmacol; 2008 Apr; 75(8):1601-9. PubMed ID: 18313035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
    Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
    J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of proton-coupled conformational dynamics of SARS and MERS coronavirus papain-like proteases: Implication for designing broad-spectrum antiviral inhibitors.
    Henderson JA; Verma N; Harris RC; Liu R; Shen J
    J Chem Phys; 2020 Sep; 153(11):115101. PubMed ID: 32962355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
    Akaji K; Konno H
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.
    Lindner HA; Fotouhi-Ardakani N; Lytvyn V; Lachance P; Sulea T; Ménard R
    J Virol; 2005 Dec; 79(24):15199-208. PubMed ID: 16306591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.